News Briefs: Supreme Court Declines PBM Fiduciary Responsibility Case

The U.S. Supreme Court declined on June 27 to hear a case that could have saddled PBMs with a fiduciary responsibility to a clients under ERISA. The case, a class action lawsuit titled John Doe v. Express Scripts, considered whether PBMs have a fiduciary duty to lower drug prices for clients, which is not the standard required by existing law or industry practice. However, some proposals currently under consideration by Congress would impose such a requirement, which could end practices such as spread pricing.

© 2023 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

pharmacists
September 14

‘Delinking’ PBM Pay From Drug Prices Comes With High Cost, Economist Argues

READ MORE
capitol-dome
September 14

House Committees Proffer Modest PBM Reform Bill

READ MORE
blurry-judge
September 14

Legal Challenges to Drug Price Negotiations Could Have Broad Implications

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today